Evidence map›Paper›PMID 41555110›Full record

ArticleCEN case reports2026

Repeat kidney biopsy reveals new-onset IgA nephropathy in a patient with ANCA-associated vasculitis.

Seina Iwami, Masahiro Eriguchi, Takaaki Kosugi, Riri Furuyama, Shunsuke Kitamura, Kaori Tanabe, Masaru Matsui, Ken-Ichi Samejima, Kazuhiko Tsuruya

Abstract readCase Reports
In one paragraph

Article in CEN case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Seina IwamiDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Masahiro EriguchiDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan. meriguci@naramed-u.ac.jp.ORCID 0000-0001-8422-7314
Takaaki KosugiDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Riri FuruyamaDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Shunsuke KitamuraDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Kaori TanabeDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Masaru MatsuiDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Ken-Ichi SamejimaDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.
Kazuhiko TsuruyaDepartment of Nephrology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara, 634-8521, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microscopic polyangiitis (MPA) is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Although relapse during maintenance therapy is relatively common, the coexistence or subsequent development of other glomerular diseases, such as IgA nephropathy, is rare. We report the case of an 81-year-old woman diagnosed with renal-limited AAV nine years earlier. Initial presentation was characterized by elevated myeloperoxidase (MPO)-ANCA levels and crescentic glomerulonephritis. Remission was achieved with prednisolone, and her serum creatinine level remained stable at approximately 0.9 mg/dL with low-dose maintenance therapy. Over the course of follow-up, she experienced two episodes of MPO-ANCA elevation accompanied by microscopic hematuria, both of which responded to an increased dose of prednisolone. At the current presentation, the MPO-ANCA level had been gradually increasing, and she developed proteinuria (3.44 g/gCr), microscopic hematuria (20-29/high-power field), and an elevated serum creatinine level (1.28 mg/dL), suggestive of a relapse of AAV presenting as rapidly progressive glomerulonephritis. However, a repeat kidney biopsy revealed new-onset IgA nephropathy. This case highlights the new-onset development of IgA nephropathy during long-term maintenance therapy for MPA. It underscores the importance of considering alternative glomerular pathologies and performing repeat kidney biopsy in patients with established AAV who present with clinical deterioration. Given the rarity of coexisting AAV and IgA nephropathy, further case accumulation and investigation are warranted to better understand their potential association.

Indexed as

Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisGlomerulonephritis, IGAKidneyMicroscopic PolyangiitisAged, 80 and overAntibodies, Antineutrophil CytoplasmicBiopsyCreatinineFemaleHematuriaHumansPeroxidasePrednisoloneProteinuriaRecurrenceAntibodies, Antineutrophil CytoplasmicCreatininePeroxidasePrednisoloneANCA-associated vasculitisIgA nephropathyKidney biopsyMicroscopic polyangiitisRelapse

Identifiers

PMID41555110
PMCPMC12816495

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.